Precision manufacturing company hits fresh high of ₹1,148 as investors track strong global manufacturing opportunity, China+1 tailwinds and expansion plans

₹22,569-crore offer attracts 12.99 crore bids against 8.86 crore shares; NII subscription reaches 2.34 times while retail portion remains below full subscription

EMA’s positive CHMP opinion for Pebrilzo marks a key regulatory milestone for Biocon Biologics, with the drug aimed at expanding access to treatment for HER2-positive breast cancer

Proposed Warner Bros. Deal Concessions Could Include Theatrical Release Commitments, California Investment and Potential Miramax Divestment

Brent slips to $101.71 and WTI falls below $100 as markets weigh possible diplomatic engagement, recovering Saudi shipments and continuing Middle East supply risks

IMD forecasts heavy to very heavy rain in north coastal Andhra Pradesh, south Odisha, Telangana, Chhattisgarh and Vidarbha as the weather system strengthens

Heavy rain, strong winds and landslide risks are prompting warnings across eastern Japan as Typhoon Dujuan moves toward the Pacific coast

Accel-backed fintech platform Moneyview is set to open its IPO on September 24, with a ₹750 crore fresh issue and an offer for sale of up to 100.49 million shares

Emkay retains ‘Add’ rating with ₹410 target as Tata Capital’s loan growth, asset quality, credit costs and profitability remain broadly aligned with management guidance